← All trials
NCT02661685
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2016
- Primary completion
- Oct 31, 2019
- Completion date
- Oct 31, 2019
- First posted
- Jan 22, 2016
- Last posted
- Feb 18, 2021
- Enrollment
- 6
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of TaiwanLead sponsor
- Academia Sinica, TaiwanCollaborator
- Chang Gung UniversityOverall official - principal investigator
- Government of TaiwanCollaborator
- Government of TaiwanReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.